Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences (GILD – Research Report) yesterday and set a price target of ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw some participants achieving an 88.94% reduction in viral load. The Japanese ...

We’re still in the early stages of RSV season, but doctors are already worried about a rise in cases. As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, ...

"Originally, it was only going to be 1 or 2, but I changed my university plans, which meant I could keep more," the owner said.

A clip showing passengers demanding to be let out of a delayed flight from Mumbai to Dubai has clocked over 28 million views on Instagram. Viral Video: A man recently met the street food vendor ...